Clinical Trial

Rice Bran Supplementation for Radiation-Induced Oral Mucositis in Head and Neck Cancer

Study acronym: RICE-MUC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 21, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to find out if taking rice bran supplements can help reduce the painful mouth sores (oral mucositis) that often occur in patients with head and neck cancer who receive radiation therapy. The trial will include adult patients undergoing radiation treatment. Participants will be given rice bran supplements during their therapy to see if it can lessen these side effects and improve their overall quality of life.
Trial Details
NCT Number NCT07242859
Lead Sponsor Christina Milad Lobos
Conditions Radiation-Induced Oral Mucositis, Head & Neck Cancer, Head & Neck Squamous Cell Carcinoma
Enrollment 80 participants
Start Date 2023-01-15
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-21